Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin H Voss

Showing results (121-130 of 141) with videos related to

Pageof 15
Sort By:
Nature Communications|October 8, 2016
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsetsYing-Bei Chen, Jianing Xu, Anders Jacobsen Skanderup, et al.
European Urology|October 19, 2016
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell CarcinomaJames J Hsieh, David Chen, Patricia I Wang, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
European Urology Oncology|October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic TestingHong Truong, Rania Sheikh, Ritesh Kotecha, et al.
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
European Urology Focus|October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 TherapyJarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
JAMA Oncology|July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
Nature Immunology|July 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccineRamin Sedaghat Herati, David A Knorr, Laura A Vella, et al.
Pageof 15

Showing results (121-130 of 141) with videos related to

Sort By:
Pageof 15
Nature Communications|October 8, 2016
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsetsYing-Bei Chen, Jianing Xu, Anders Jacobsen Skanderup, et al.
European Urology|October 19, 2016
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell CarcinomaJames J Hsieh, David Chen, Patricia I Wang, et al.
European Urology|November 5, 2025
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell CarcinomaMark T Dawidek, Lina Posada Calderon, Parantu K Shah, et al.
European Urology Oncology|October 16, 2021
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic TestingHong Truong, Rania Sheikh, Ritesh Kotecha, et al.
Genome Medicine|December 19, 2022
Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escapeMahdi Golkaram, Fengshen Kuo, Sounak Gupta, et al.
European Urology Focus|October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 TherapyJarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
JAMA Oncology|July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell CarcinomaMaria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
Nature Immunology|July 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccineRamin Sedaghat Herati, David A Knorr, Laura A Vella, et al.
Pageof 15